| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Departments of Gastrointestinal Medical Oncology [B. W., Q. X., Q. S., X. L., J. L. A., K. X.], and Cancer Biology [K. X.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
Previous studies have shown that enforced expression of IFN-ß suppressed tumor growth and metastasis. In this report, we determined whether the induction of nitric oxide synthase II (NOS II) gene is required for IFN-ß-mediated antitumor activity using syngeneic mice with intact (NOS II+/+) or genetically disrupted (NOS II-/-) NOS II gene. PANC02-H7 highly metastatic murine pancreatic adenocarcinoma cells were transfected with an IFN-ß expression vector or a control pcDNA3 vector. The parental PANC02-H7, control vector-transfected, and IFN-ß-transfected cells were orthotopically implanted into the pancreas of syngeneic NOS II+/+ and NOS II-/- C57BL/6J mice. In NOS II+/+ C57BL/6J, both parental and control vector-transfected cells grew progressively in pancreas and produced numerous liver metastases and a large amount of malignant ascites, whereas IFN-ß-secreting cells did not. In NOS II-/- C57BL/6J mice, however, IFN-ß-secreting cells grew much more aggressively. Higher NO induction was detected in NOS II+/+ mice that received injections with IFN-ß-secreting cells than with the control cells, but it was not detected in NOS II-/- mice. These data suggested that IFN-ß secreted from tumor cells stimulates NO production by host cells and suppresses tumor growth and metastasis.
This article has been cited by other articles:
![]() |
Z. Peng, D. Wei, L. Wang, H. Tang, J. Zhang, X. Le, Z. Jia, Q. Li, and K. Xie RUNX3 Inhibits the Expression of Vascular Endothelial Growth Factor and Reduces the Angiogenesis, Growth, and Metastasis of Human Gastric Cancer. Clin. Cancer Res., November 1, 2006; 12(21): 6386 - 6394. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Le, D. Wei, S. Huang, J. R. Lancaster Jr., and K. Xie Nitric oxide synthase II suppresses the growth and metastasis of human cancer regardless of its up-regulation of protumor factors PNAS, June 14, 2005; 102(24): 8758 - 8763. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Thomas, M. G. Espey, L. A. Ridnour, L. J. Hofseth, D. Mancardi, C. C. Harris, and D. A. Wink Hypoxic inducible factor 1{alpha}, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide PNAS, June 15, 2004; 101(24): 8894 - 8899. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Schmidt, C. Ziske, A. Marten, S. Endres, K. Tiemann, V. Schmitz, M. Gorschluter, C. Schneider, T. Sauerbruch, and I. G. H. Schmidt-Wolf Intratumoral Immunization with Tumor RNA-Pulsed Dendritic Cells Confers Antitumor Immunity in a C57BL/6 Pancreatic Murine Tumor Model Cancer Res., December 15, 2003; 63(24): 8962 - 8967. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wei, E. L. Richardson, K. Zhu, L. Wang, X. Le, Y. He, S. Huang, and K. Xie Direct Demonstration of Negative Regulation of Tumor Growth and Metastasis by Host-inducible Nitric Oxide Synthase Cancer Res., July 15, 2003; 63(14): 3855 - 3859. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Qiu, F.W. Orr, D. Jensen, H. H. Wang, A. R. McIntosh, B. B. Hasinoff, D. M. Nance, S. Pylypas, K. Qi, C. Song, et al. Arrest of B16 Melanoma Cells in the Mouse Pulmonary Microcirculation Induces Endothelial Nitric Oxide Synthase-Dependent Nitric Oxide Release that Is Cytotoxic to the Tumor Cells Am. J. Pathol., February 1, 2003; 162(2): 403 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Medeiros, A. Morais, A. Vasconcelos, S. Costa, D. Pinto, J. Oliveira, P. Ferreira, and C. Lopes Outcome in Prostate Cancer: Association with Endothelial Nitric Oxide Synthase Glu-Asp298 Polymorphism at Exon 7 Clin. Cancer Res., November 1, 2002; 8(11): 3433 - 3437. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Bauer, B. H. Morrison, R. W. Grane, B. S. Jacobs, S. Dabney, A. M. Gamero, K. A. Carnevale, D. J. Smith, J. Drazba, B. Seetharam, et al. Effects of Interferon {beta} on Transcobalamin II-Receptor Expression and Antitumor Activity of Nitrosylcobalamin J Natl Cancer Inst, July 3, 2002; 94(13): 1010 - 1019. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |